Furthermore, IL-10 DC have been shown to induce anergic regulatory CD4+ and CD8+ T cells (iTregs), which inhibit activated cytotoxic and helper T cells, resulting in a failure to kill melanoma cells [17], [19]. Here, CD8A is linked to melanoma.